TECH today
$72.80-$0.04 (-0.05%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bullish
1 hourBullish
15 minBearish
5 minAscending Triangle
Daily trend turns down below $72.33
Key levels
Resistance$73.67
Resistance$72.88
Support$72.60
Support$72.38
Latest news & SEC filings
DealMerck KGaA confirms plan to acquire Bio-Techne
NewsTechstep ASA updates its registered share capital
DealTechstep ASA gets fresh recommendation and revised supplier ranking tied to DFØ framework deal
EarningsBio-Techne posts Q1 fiscal 2027 results, advances Merck KGaA merger
DealTechstep ASA issues shares for underwriting commission
All TECH news →About Bio-Techne
Bio-Techne makes and sells biological research tools, lab instruments and related support offerings used in scientific study, clinical testing and bioprocessing. It runs two segments: Protein Sciences, which supplies proteins, antibodies, chemicals and protein analysis equipment, and Diagnostics and Spatial Biology, which provides clinical controls, assays and tissue analysis products. Buyers include university scientists, drug and biotech firms, contract labs, diagnostic makers and instrument manufacturers. The company is based in Minneapolis, Minnesota and sells across North America, Europe and Asia.
Based on the company's 10-K filed Aug 24, 2026.
Nasdaq · Healthcare
BIO-TECHNE Corp (TECH)
What Is the Price Target for TECH?
SEPT Low Target
$50.00
SEPT Mid Target
$73.00
SEPT High Target
$73.00
Analyst Consensus
$73.00
Is TECH a Buy or Sell Right Now?
Thesis
- •Revenue growing -0.4% YoY with SLOWING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TECH.
Start Free Trial →Is TECH Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$60.46
40
Moat Score
NARROW
7/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with TECH?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
BUYING
6 buys / 8 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Kelderman Kim | director officer | Sale | 2,385 | $173K | Nov 1, 2026 |
| Hippel James | officer | Buy | 11,545 | - | Nov 1, 2026 |
| Hippel James | officer | Sale | 5,096 | $370K | Nov 1, 2026 |
| HIGGINS JOHN L | director | Buy | 15,940 | - | Sep 28, 2026 |
| HIGGINS JOHN L | director | Sale | 5,562 | $403K | Sep 28, 2026 |
| BAUMGARTNER ROBERT V | director | Buy | 15,940 | - | Sep 22, 2026 |
| BAUMGARTNER ROBERT V | director | Sale | 5,559 | $403K | Sep 22, 2026 |
| Bohnen Shane | officer | Buy | 448 | $21K | Jul 23, 2026 |
| Bohnen Shane | officer | Sale | 344 | $25K | Jul 23, 2026 |
| Crouse Steven C. | officer | Sale | 216 | $11K | Jun 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TECH Growth Story
Revenue YoY
-0.4%
3yr Revenue CAGR
2.3%
EPS Growth YoY
152.17%
FCF Growth YoY
2.6%
Revenue Trend
SLOWING
Dark Pool Trades for TECH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TECH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:07:03 | $72.80 | 4,409 | $$321K | SELL |
| 21:00:28 | $72.80 | 3,173 | $$231K | BUY |
| 21:00:28 | $72.80 | 5,446 | $$396K | BUY |
| 21:00:27 | $72.80 | 6,807 | $$496K | BUY |
| 21:00:24 | $72.80 | 1,412 | $$103K | BUY |
5 dark pool trades shown · $$1.5M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for TECH
PREVIEWSEPT Investing provides real-time options flow tracking for TECH, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $75 | Jan 21 | 434 | $$110 | 2 | SWEEP |
| CALL | $75 | Jan 21 | 434 | $$50 | 1 | SWEEP |
| CALL | $75 | Jan 21 | 434 | $$50 | 1 | SWEEP |
| CALL | $75 | Jan 21 | 434 | $$50 | 1 | SWEEP |
| CALL | $45 | Jan 19 | 798 | $$2887 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About TECH
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for TECH. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
$TECH earnings are due Wed Nov 11.
SEPT Brain on $TECH -- Bullish TECH at $54.02. Uptrend holds while above $53.60. $62.46 target still in play. The Play: Watch for a decisive move from current levels with volume confirmation.. Dire...
Join 3,500+ traders discussing TECH in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BIO-TECHNE Corp (TECH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TECH — frequently asked questions
What is TECH stock price today?
BIO-TECHNE Corp (TECH) is at $72.80, down 0.05% (-$0.04) at the Nov 13, 2026 close.
Why is TECH stock moving today?
Latest TECH news — Nov 11, 2026: Merck KGaA confirms plan to acquire Bio-Techne · Nov 11, 2026: Techstep ASA updates its registered share capital
What is the TECH price target?
The average analyst price target for TECH is $73.00, ranging from $50 to $73, based on 9 analysts. Latest: Wells Fargo downgrade on Aug 13, 2026.
What do analysts rate TECH?
Analyst ratings for TECH: 0 Buy, 12 Hold, 1 Sell — consensus Hold.
Did TECH beat earnings?
TECH last reported on Nov 4, 2026: EPS $0.42 vs $0.44 expected — a miss of 4.5%.
What is TECH's P/E ratio?
TECH trades at a P/E of 66.2 vs a Healthcare average of 17.4.
Does TECH pay a dividend?
Yes. TECH's dividend yield is 0.62%.
What are TECH support and resistance levels?
Support: $72.60, $72.38, $72.10. Resistance: $72.88, $73.67, $74.27.
What are insiders doing with TECH?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on TECH?
Nov 11, 2026: Merck KGaA confirms plan to acquire Bio-Techne · Nov 11, 2026: Techstep ASA updates its registered share capital · Nov 10, 2026: Techstep ASA gets fresh recommendation and revised supplier ranking tied to DFØ framework deal